Mumbai, Feb. 23 -- Lupin has received the approval from European Commission for its biosimilar ranibizumab, RanluspecTM (for vials and pre-filled syringes), following the recent positive opinion from the Committee for Medicinal Products for Human Use.

Published by HT Digital Content Services with permission from Capital Market....